18 results
Keyword valneva Remove keyword
Categories
Human Remove Human filter
Type of content
News Remove News filter
-
List item
News: EMA recommends Valneva’s COVID-19 vaccine for authorisation in the EU
CHMP, Last updated: 23/06/2022EMA recommends Valneva’s COVID-19 vaccine for authorisation … inactivated, adjuvanted) Valneva is now authorised across … inactivated, adjuvanted) Valneva for use in the primary vaccination … -
List item
News: EMA starts rolling review of Valneva’s COVID-19 vaccine (VLA2001)
CHMP, Last updated: 02/12/2021EMA starts rolling review of Valneva’s COVID-19 vaccine (VLA2001 … EMA starts rolling review of Valneva’s COVID-19 vaccine (VLA2001 … -
List item
News: Meeting highlights from the Committee for Medicinal Products for Human Use (CHMP) 20-23 June 2022
CHMP, Last updated: 24/06/2022Valneva … -
List item
News: Meeting highlights from the Committee for Medicinal Products for Human Use (CHMP) 20 - 23 February 2023
CHMP, Last updated: 24/02/2023Valneva … -
List item
News: Meeting highlights from the Committee for Medicinal Products for Human Use (CHMP) 12-15 September 2022
CHMP, Last updated: 22/09/2022Valneva … -
List item
News: Meeting highlights from the Pharmacovigilance Risk Assessment Committee (PRAC) 13 - 16 March 2023
PRAC, Last updated: 17/03/2023 -
List item
News: Meeting highlights from the Pharmacovigilance Risk Assessment Committee (PRAC) 28 November - 1 December 2022
PRAC, Last updated: 02/12/2022 -
List item
News: Meeting highlights from the Pharmacovigilance Risk Assessment Committee (PRAC) 26-29 September 2022
PRAC, Last updated: 30/09/2022 -
List item
News: Human medicines: highlights of 2022
Last updated: 16/02/2023Vyvgart Evusheld Paxlovid COVID-19 Vaccine Valneva VidPrevtyn Beta Covid-19 Cancer Breyanzi Camcevi Carvykti Celdoxome … 17-year-olds COVID-19 Vaccine Valneva, primary vaccination in adults … -
List item
News: EMA annual report 2022 published
Last updated: 15/05/2023 -
List item
News: Meeting highlights from the Pharmacovigilance Risk Assessment Committee (PRAC) 24 - 27 October 2022
PRAC, Last updated: 28/10/2022 -
List item
News: Meeting highlights from the Pharmacovigilance Risk Assessment Committee (PRAC) 6 - 9 February 2023
PRAC, Last updated: 10/02/2023 -
List item
News: Meeting highlights from the Pharmacovigilance Risk Assessment Committee (PRAC) 9 - 12 January 2023
PRAC, Last updated: 13/01/2023 -
List item
News: EMA and ECDC recommendations on heterologous vaccination courses against COVID-19: ‘mix-and-match’ approach can be used for both initial courses and boosters
Last updated: 07/12/2021vaccine, Novavax’ vaccine, Valneva’s vaccine and CoronaVac are … -
List item
News: EMA publishes annual report 2021
Last updated: 10/06/2022 -
List item
News: Report: How EU ensured safety of medicines during COVID-19
Last updated: 22/06/2023 -
List item
News: Meeting highlights from the Pharmacovigilance Risk Assessment Committee (PRAC) 11-14 January 2021
PRAC, Last updated: 15/01/2021 -
List item
News: Meeting highlights from the Pharmacovigilance Risk Assessment Committee (PRAC) 25-28 October 2021
PRAC, Last updated: 29/10/2021